Wayne Dimech examines the quality - or lack thereof - of SARS-Cov-2 testing. Wayne Dimech is Executive Manager, Scientific and Business Relations at NRL, Australia (NRL) in Melbourne. He is a recognized expert in infectious disease serology and laboratory quality.
A few months into the Covid19 crisis, we need to stop treating it as a short-term crisis and start preparing it like it's a long-term emergency.
We know how to change QC frequency in a data-driven, evidence-based, patient-risk focused way. But we don't seem to be doing it at all.
Expanding on a previous lesson on Clinical Agreement, Dr. Westgard discusses the Predictive Value of a Laboratory Test
It's October 2020. Time to take a hard look at truth, untruth, and the consequences of pretending there's no difference.
By mid-October 2020, the list of methods for SARS-COV-2 testing (molecular, antigen, rapid, and serology), broke the 870 mark. Rather than ask laboratories to evaluate more than 870 possibilities, we've narrowed the candidates down to a short list.
Continuing in our series of Sigma analysis of the leading diagnostic platforms, we turn our attention to the Abbott Alinity, and assess what goals can be achieved by this chemistry instrument.
WESTGARD QC promotes the latest news, education, and tools in the quality control field. Our goal is to bring tools, technology and training into today's healthcare industry — by featuring QC lessons, QC case studies and frequent essays from leaders in the quality control area. This is also a reference source for quality requirements, including CLIA requirements for analytical quality. This website features the best explanation of the Multirule ("Westgard Rules") and how to use them. For laboratory and healthcare professionals looking for educational and reference material in the quality control field.
THIS IS THE WEBSITE FOR YOU!
